Key regions: United States, South Korea, Japan, Canada, India
The Digestive & Intestinal Remedies (Pharmacies) market in NAFTA is experiencing steady growth due to changing customer preferences and underlying macroeconomic factors. Customer preferences in the Digestive & Intestinal Remedies market have shifted towards natural and herbal remedies, as consumers become more health-conscious and seek products with fewer side effects. This trend is driven by a growing awareness of the benefits of natural ingredients and a desire for more holistic approaches to healthcare. Additionally, consumers are increasingly seeking convenience in their healthcare choices, leading to a rise in demand for over-the-counter remedies that can be easily purchased at pharmacies. Trends in the market include the growing popularity of probiotics and digestive enzymes as consumers recognize their potential to improve gut health. Probiotics, in particular, have gained traction as they are believed to promote a healthy balance of bacteria in the gut, leading to improved digestion and overall well-being. This trend is further fueled by the increasing prevalence of digestive disorders such as irritable bowel syndrome and acid reflux, which has created a larger consumer base for Digestive & Intestinal Remedies. Local special circumstances within the NAFTA region also contribute to the growth of the Digestive & Intestinal Remedies market. In the United States, for example, the high prevalence of fast food consumption and sedentary lifestyles has led to an increase in digestive health issues, driving demand for remedies. In Canada, an aging population and rising healthcare costs have prompted individuals to take a more proactive approach to their health, leading to increased sales of Digestive & Intestinal Remedies. In Mexico, the market is driven by a combination of factors including a growing middle class, increasing consumer awareness, and a strong tradition of natural remedies. Underlying macroeconomic factors, such as GDP growth and disposable income, also play a role in the development of the Digestive & Intestinal Remedies market in NAFTA. As economies in the region continue to grow, consumers have more purchasing power and are willing to spend on healthcare products that improve their quality of life. Additionally, the increasing prevalence of digestive health issues and the rising cost of prescription medications have led consumers to seek affordable alternatives, further driving the demand for Digestive & Intestinal Remedies. Overall, the Digestive & Intestinal Remedies (Pharmacies) market in NAFTA is experiencing growth due to changing customer preferences towards natural remedies, increasing awareness of digestive health issues, and underlying macroeconomic factors. As consumers continue to prioritize their health and seek convenient and affordable solutions, the market is expected to continue its upward trajectory.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
